Viewing Study NCT01324492


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2026-02-01 @ 2:21 AM
Study NCT ID: NCT01324492
Status: COMPLETED
Last Update Posted: 2014-12-30
First Post: 2011-03-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Neuroendocrine Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None phase Ib, View
None RAD001, View
None advanced pulmonary neuroendocrine tumor View